✦ LIBER ✦

Comparison of daunorubicin and anthrapyrazolone sensitivity and transport in resistant cell lines

✍ Scribed by McGown, A; Poppitt, DG; Fox, BW

Book ID: 109835883
Publisher: Nature Publishing Group
Year: 1987
Tongue: English
Weight: 588 KB
Volume: 56
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1987.283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of daunorubicin carbonyl reduc

Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells

✍ Michael Soldan; Karl J. Netter; Edmund Maser 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 947 KB

Metabolism of daunorubicin in sensitive

Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells

✍ Danielle Londos-Gagliardi; Roger Baurain; Jacques Robert; Geneviève Aubel-Sadron 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 401 KB

Characterization and modulation of drug

Characterization and modulation of drug transport kinetics in K562 cl.6 daunorubicin-resistant cell line

✍ Xu-Rong Jiang; Marion G. Macey; Peter W. Collins; Adrian C. Newland 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 617 KB

Subcellular localization of daunorubicin

Subcellular localization of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells

✍ Danielle Londos-Gagliardi; Geneviève Aubel-Sadron; René Maral; André Trouet 📂 Article 📅 1980 🏛 Elsevier Science ⚖ 362 KB

Differential cytotoxicity of Combretasta

Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines

✍ Alan T. McGown; Brian W. Fox 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 256 KB

Contribution of drug transport and reduc

Contribution of drug transport and reductases to daunorubicin resistance in human myelocytic cells

✍ Geetha Vasanthakumar; Nahed K. Ahmed 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 662 KB

We developed three daunorubicin (D1)-resistant sublines (ML1/I, II, III) from the human myelocytic cell line (ML1). These sublines were 28-, 70- and 162-fold more resistant than sensitive (ML1/S) cells to the cytotoxicity of D1 and were cross-resistant to adriamycin, epiadriamycin, actinomycin D, VP